HoJuhn Song is the founder of PineTree Therapeutics. PineTree Therapeutics has raised $24M in total funding. Latest round: Series A.
HoJuhn Song is the Co-Founder and CEO of PineTree Therapeutics, a preclinical stage biotech company founded in 2019 and headquartered in Cambridge, MA. The company is developing disruptive therapies in oncology, immuno-oncology, and other diseases, focusing on hard-to-treat cancers and viral diseases. PineTree Therapeutics has developed TAER-TAB™ and ViTRAP™ technologies.
Full founder directory · Investor directory · Company funding database · Fundraising library